Infrastructure Capital Advisors LLC purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 26,324 shares of the company’s stock, valued at approximately $3,383,000.
A number of other large investors have also added to or reduced their stakes in the company. Frazier Financial Advisors LLC purchased a new position in shares of Merck KGaA in the second quarter valued at about $25,000. Rakuten Securities Inc. purchased a new stake in shares of Merck KGaA during the second quarter worth about $27,000. Solstein Capital LLC purchased a new stake in shares of Merck KGaA during the second quarter worth about $33,000. Burk Holdings LLC bought a new stake in shares of Merck KGaA in the second quarter worth about $39,000. Finally, Bard Associates Inc. bought a new stake in shares of Merck KGaA in the second quarter worth about $60,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Price Performance
Shares of OTCMKTS:MKGAF opened at $163.21 on Monday. The stock’s 50-day moving average is $162.62 and its 200 day moving average is $148.44. The company has a market cap of $21.09 billion, a PE ratio of 24.92 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
